VIB

What VIB does

VIB (Vlaams Instituut voor Biotechnologie VZW) is a Belgian non-profit life sciences research institute founded in 1996 and headquartered in Ghent, with more than 1,900 employees drawn from over 60 nationalities. The institute operates eight research centers spanning cancer biology, immunology and inflammation, neuroscience, plant systems biology, microbiology, structural biology, medical biotechnology, and AI/computational biology, alongside twelve core technology facilities covering bioimaging, flow cytometry, metabolomics, nanobody production, nucleomics, protein production, proteomics, single-cell analysis, spatial omics, screening, technology scouting, and research data services. Its proprietary platforms include the CREsted deep-learning enhancer design tool, the Trait Foundry multiplex genome editing system, and the IONBOT mass spectrometry software.

VIB monetizes primarily through three channels: fee-for-service access to its core facilities (booked via the CONNECT platform), technology transfer and licensing of internally developed IP, and training and conference services. Commercialization is heavily oriented around spin-off creation; recent examples include Rainbow Crops (2025, €9.7M seed led by LIFTT EuroInvest) and a broader portfolio spanning nanobody-based therapeutics and AgBio. The institute is structurally embedded in the Flemish biotech ecosystem through joint centers with KU Leuven and Ghent University, hosts the Belgian ELIXIR bioinformatics node via its Data Core, and has established international research partnerships (e.g., the renewed synthetic biology collaboration with the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, December 2025). Leadership is anchored by General Director Christine Durinx and CFO Rik Audenaert.

Name

VIB

Legal name

Vlaams Instituut voor Biotechnologie VZW

Website

https://vib.be

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

VIB (Vlaams Instituut voor Biotechnologie VZW) is a Belgian non-profit life sciences research institute operating eight research centers and twelve core technology facilities, serving academic researchers, pharmaceutical/biotech companies, and AgTech partners through fee-for-service access, licensing, and spin-off commercialization.

Ownership category

akta.pro rank

Product category

Life Sciences Research & Biotechnology Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industry

Analytical Instruments & Chromatography Systems (HLAGAIAA)

Keywords

• Life sciences research
• Biotechnology services
• Core research facilities
• Technology transfer
• Biotech spin-offs

Headquarters

HQ city

Gent

HQ country

Belgium

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Core Facility Services: VIB provides fee-for-service access to specialized research technology platforms including proteomics, screening, protein production, metabolomics, and other core facilities. Services are booked through the CONNECT platform.
2. Technology Transfer & Licensing: VIB commercializes research outcomes through technology transfer, licensing agreements, and creation of spin-off companies.
3. Training & Conferences: VIB Training & Conferences provides scientific and technical skill courses and organizes conferences for researchers.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

VIB operates as a life sciences research institute providing fee-for-service access to 12 specialized core technology facilities (bioimaging, flow cytometry, metabolomics, nanobody production, nucleomics, protein production, proteomics, screening, single cell, spatial omics, data services, and technology scouting). The institute conducts fundamental and translational research across eight research areas including cancer, neuroscience, plant biology, microbiology, and computational biology, while commercializing discoveries through technology licensing and the creation of spin-off companies.

Product overview

VIB operates as a life sciences research institute offering a platform of core technology facilities and services. The main offerings include: the Tech Portfolio of 12 core facilities (Bioimaging, Flow Cytometry, Metabolomics, Nanobody Production, Nucleomics, Protein Production, Proteomics, Research Data Services, Screening, Single Cell Technology, Spatial Catalyst, and Technology Scouting); specialized production cores for proteins, proteomics, screening, and metabolomics analysis; AI/computational biology services through VIB.AI; research data management via the Data Core; and training & conferences for scientific education. VIB also maintains software tools including IONBOT for mass spectrometry analysis and Gateway Vectors for cloning research.

Differentiator

Problem solved

Functional benefit

Products and services

• VIB Tech Portfolio (Core Technology Facilities) A portfolio of 12 specialized core technology facilities providing research services including bioimaging, flow cytometry, metabolomics, nanobody production, nucleomics, protein production, proteomics, research data services, screening, single cell technology, spatial omics, and technology scouting for academic researchers and industry partners.
• VIB Protein Core Biological production facility offering end-to-end development, production and characterization of high-quality proteins using microbial and mammalian expression platforms, including FastScreen, FastFold, and FastClean optimization tools for academic and industrial researchers.
• VIB Data Core Research data infrastructure providing hardware and compute cluster management, research data flow streamlining, software tools for scalable analysis, and hosting the Belgian ELIXIR node for unified European life science data access.
• VIB Proteomics Core Mass spectrometry-based proteomics services providing protein characterization, biomarker discovery, and novel drug target identification for academic and pharmaceutical researchers.
• VIB Screening Core High-throughput screening platform with automated liquid handling and high-content imaging for bioactive substance identification in chemical biology, drug discovery, and agrochemical research.
• VIB Metabolomics Core Ghent Metabolomics facility specializing in secondary metabolism with Ion Mobility Mass Spectrometry and a library of over 5000 secondary metabolites for comparative metabolic profiling of biological samples.
• VIB Training & Conferences Scientific and technical skill development courses and conference organization for VIB and external researchers, covering topics from basic science to specialized methodologies in life sciences.
• VIB.AI: Center for AI & Computational Biology Research center focused on AI and computational biology, applying machine learning and computational methods to biological data analysis, including algorithms, genomics, and multi-omics interpretation.
• VIB IONBOT Mass spectrometry data analysis software licensed for non-commercial research use, developed by Dr. Sven Degroeve and Prof. Lennart Martens at VIB.

Quantifiable outcome

• Created multiple successful spin-off companies including Rainbow Crops (raised €9.7M seed funding)
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core.

• Tianjin Institute of Industrial Biotechnology (TIB) - Chinese Academy of SciencescoreStrategic or Co-development Partner · 15 December 2025Renewed joint center agreement for synthetic biology between VIB and TIB/CAS, building on 2020 collaboration focused on yeast synthetic biology and plant natural product biosynthesis. Expanded partnership adds new research priorities including chassis cell metabolic mechanisms, pathway design, microbial protein production, and low-carbon compound valorization. Prof. Kevin Verstrepen named Distinguished Scientist under CAS CO2 FIX International Fellowship Initiative.
• European Life Sciences Coalition (ELSC)coreStrategic or Co-development PartnerCoalition of European life science venture capital firms and research institutions launched to address structural funding gaps. VIB is a member of this coalition whose members manage over €24 billion in assets, advocating for better mobilization of capital and more integrated investment policies to reverse the trend of European biotechs listing abroad.
• KU LeuvencoreStrategic or Co-development PartnerLong-standing research partnership with KU Leuven including joint research centers (VIB-KU Leuven Center for Neuroscience, VIB-KU Leuven Center for Brain & Disease Research), collaborative research programs, and co-authored publications on Alzheimer's disease, gene regulation, and other life sciences topics.
• Ghent University (UGent)coreStrategic or Co-development PartnerStrategic research partnership with Ghent University including joint centers (VIB-UGent Center for Plant Systems Biology, VIB-UGent Center for Medical Biotechnology, VIB-UGent Center for Microbiology), shared infrastructure, and collaborative research programs.
• ELIXIR BelgiumcoreStrategic or Co-development PartnerVIB Data Core serves as the host for the Belgian ELIXIR node, which is part of the European research infrastructure for biological data. This partnership provides unified access to data management and computational resources across Europe.
• EMPHASIS (European Research Infrastructure for Plant Phenotyping)coreStrategic or Co-development PartnerPan-European network of over 200 advanced plant phenotyping facilities coordinated from Belgium. VIB participates as part of the Flemish research infrastructure contributing to sustainable agriculture, plant-based innovation, and climate resilience research.
• Flemish Strategic Research CenterscoreStrategic or Co-development PartnerVIB collaborates with Flanders Make, imec, and VITO as part of the Industry Forum to accelerate translation of scientific research into industrial applications. Partnership aims to address declining Flemish industry share of regional GDP (from 20% in 1990s to 14% today).

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Karolinska Institutet: Karolinska Institutet is Sweden's largest medical university with strong industry partnerships and translational research. Comparable to VIB in life sciences focus, university-affiliated biomedical research, and translational pipeline, though operating as a full university rather than dedicated research institute.
• Howard Hughes Medical Institute (HHMI): HHMI is the largest US biomedical research organization with $20B+ endowment, supporting 300+ investigators. Comparable to VIB in non-profit biomedical research mission, investigator-driven model, and translational output, though larger in scope and focused on US academic partners.
• CNRS (Centre national de la recherche scientifique): CNRS is France's largest public research organization with 30,000+ staff across 200+ laboratories including life sciences. Comparable to VIB in scale, public funding model, multi-disciplinary life sciences research, and university partnership structure across France.

Direct peers

• Helmholtz Association: Helmholtz Association is Germany's largest scientific organization operating 18 research centers with €5B+ annual budget across life sciences, energy, and earth systems. Comparable to VIB in scale, public funding model, multi-disciplinary life sciences focus, and translational research orientation.
• Broad Institute of MIT and Harvard: The Broad Institute is a genomics and biomedical research institute founded by MIT and Harvard with strong translational focus and industry partnerships. Comparable to VIB in joint-university model, core technology platform focus, and translational pipeline generation including spin-outs.
• European Molecular Biology Laboratory (EMBL): EMBL is a European intergovernmental life sciences research organization operating multiple sites across Europe with strong translational research and training programs. Directly comparable to VIB as a publicly funded, multi-site European life sciences research institute with cross-university collaboration models.
• Pasteur Institute: The Pasteur Institute is a French non-profit research foundation focused on infectious disease, immunology, and developmental biology. Comparable to VIB as a non-profit biomedical research institute with core technology platforms, translational output, and university affiliation.
• Max Planck Society: Max Planck operates 80+ Max Planck Institutes conducting fundamental research in life sciences, chemistry, physics and beyond. Directly comparable to VIB in scale (20,000+ employees), structure (multi-institute, government-funded, basic and translational life sciences), and university partnership model across Germany.
• Wellcome Sanger Institute: Sanger Institute is a UK-based genomics and biodata research institute funded by Wellcome Trust, operating large-scale core sequencing facilities. Comparable to VIB in non-profit research model, core technology services, and partnership with European bioinformatics infrastructure (ELIXIR).
• Francis Crick Institute: The Crick Institute is a UK biomedical discovery institute with 1,500+ scientists and 100+ research groups. Comparable to VIB in single-institute dedicated biomedical focus, core technology platform model, and translational research orientation, though UK-based.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCA9pSnamGG9AGoIfiwquvOQ
• Facebookfacebook.com/VIBLifeSciences
• LinkedInlinkedin.com/company/vib
• Instagraminstagram.com/viblifesciences
• Xx.com/VIBLifeSciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments31 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VIB